ESC Medical pays Reliant $7.5 million to settle lawsuit
This article was originally published in Clinica
ESC Medical Systems, an Israeli-based surgical and aesthetic laser company, has settled longstanding litigation between subsidiaries and a competitor laser company, Reliant Technologies. While ESC will pay $7.5 million in cash, it says that the resolution of the legal action clears the way towards making it a better prospect for potential investors.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.